Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CEP44 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NUP188 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2F - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00674 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
AMFR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JAK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPHP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C9orf3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RET - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EMC6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930075 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZDHHC18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FSCN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGEF28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCAT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100288570 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SHE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on